ANTX - Balance Sheet - AN2 Therapeutics, Inc.

Current Liabilities	10.2 M
Accounts Payable	3.32 M
Short-Term Debt	0
Other Current Liabilities	6.92 M
Non-Current Liabilities	0
Long-Term Debt	0
Other Non-Current Liabilities	0

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	21.4	15.6	27.2	12.1	4.1	5.6
Short Term Investments	62.3	91.6	68.8	46.5	0	0
Receivables	0	0	0	0	0	0
Inventory	0	0	0	0	0	0
Other Current Assets	2.3	3.2	2.6	1.6	0.2	0.1
Total Current Assets	86.3	110.5	98.6	60.1	4.2	5.7
PP&E	0	0	53 K	0	0	0
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	5.0	27.2	3.2	3.5	0	0
Other Long Term Assets	0.8	1.0	0.7	1.7	0	0
Other Assets	0	0	0	0	0	0
Total Assets	92.1	138.7	102.6	65.3	4.2	5.7
LIABILITIES
Accounts Payable	3.3	2.7	2.1	1.1	0.1	51 K
Short Term Debt	0	0	0.1	0	0	0
Other Current Liabilities	6.9	11.4	5.0	2.3	1.3	0.1
Total Current Liabilities	10.2	14.0	7.2	3.4	1.5	0.2
Long Term Debt	0	0	0	0	0	0.7
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	0	0	2 K	109.3	23.1	0
Total Liabilities	10.2	14.0	7.2	112.7	24.6	0.9
EQUITY
Common Stock	0	0	0	0	0	0
Retained Earnings	(205.8)	(154.5)	(89.7)	(47.4)	(20.3)	(5.8)
Other Accumulative Comprehensive Income/Loss	31 K	0.3	(0.4)	27 K	0	0
Total Equity	81.8	124.7	95.4	(47.4)	(20.3)	4.8
Total Liabilities and Equity	92.1	138.7	102.6	65.3	4.2	5.7
SHARES OUTSTANDING
Common Shares Outstanding	29.8	23.6	19.4	18.7	18.7	18.7

Free